textabstractWith the use of cadaver donors, the number of kidney transplantations is growing rapidly. The total number for the whole world is estimated at over 100.000. Half of these transplantations are performed in Europe. For the Netherlands the total number of renal transplantations carried out until the end of 1985 amounts to 3.000. Out of these 3.000, nearly 200 involved children under 15 years of age. In the unnatural situation of allogeneic kidney transplan- I tation, where surgeons are attempting to contravene nature by inserting foreign proteins into an unwilling host, unusual compensatory host mechanisms may take place. One of these mechanisms is the development of post-renal transplantation hypertension. Although a ...
Chronic allograft nephropathy (CAN) is the leading cause of late allograft loss after renal transpla...
A reproducible animal model is essential for the study of the pathogenesis of chronic rejection. Thi...
Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy.Back...
Post-transplant hypertension in the rat: Effects of captopril and native nephrectomy. In patients wi...
RENAL hypertension in the dog is pre-vented or diminished in severity by the presence of normally fu...
Hypertension is a common complication of kidney transplantation with the prevalence of 80%. Studies ...
Kidney transplantation is the treatment of choice for end-stage renal disease. While graft survival ...
Hypertension is one of the most common cardiovascular co-morbidities after successful kidney transpl...
Over the past 50 years various animal models of hypertension have been developed, predominantly in t...
Over the past 50 years various animal models of hypertension have been developed, predominantly in t...
Hypertension in kidney transplant recipients is a major traditional risk factor for atheroscleroti...
Hypertension is a frequent complication after renal transplantation. It contributes to the considera...
Abstract Introduction: Hypertension is nearly universal in kidney transplant and several factors ar...
Hypertension (HT) is one of the most frequent complications of solid organ transplantation; about 70...
Chronic hypertension can be induced in laboratory animals by a number of procedures. It has been ass...
Chronic allograft nephropathy (CAN) is the leading cause of late allograft loss after renal transpla...
A reproducible animal model is essential for the study of the pathogenesis of chronic rejection. Thi...
Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy.Back...
Post-transplant hypertension in the rat: Effects of captopril and native nephrectomy. In patients wi...
RENAL hypertension in the dog is pre-vented or diminished in severity by the presence of normally fu...
Hypertension is a common complication of kidney transplantation with the prevalence of 80%. Studies ...
Kidney transplantation is the treatment of choice for end-stage renal disease. While graft survival ...
Hypertension is one of the most common cardiovascular co-morbidities after successful kidney transpl...
Over the past 50 years various animal models of hypertension have been developed, predominantly in t...
Over the past 50 years various animal models of hypertension have been developed, predominantly in t...
Hypertension in kidney transplant recipients is a major traditional risk factor for atheroscleroti...
Hypertension is a frequent complication after renal transplantation. It contributes to the considera...
Abstract Introduction: Hypertension is nearly universal in kidney transplant and several factors ar...
Hypertension (HT) is one of the most frequent complications of solid organ transplantation; about 70...
Chronic hypertension can be induced in laboratory animals by a number of procedures. It has been ass...
Chronic allograft nephropathy (CAN) is the leading cause of late allograft loss after renal transpla...
A reproducible animal model is essential for the study of the pathogenesis of chronic rejection. Thi...
Hypertension increases expression of growth factors and MHC II in chronic allograft nephropathy.Back...